Viewing Study NCT04815720


Ignite Creation Date: 2025-12-25 @ 4:15 AM
Ignite Modification Date: 2026-02-25 @ 4:57 PM
Study NCT ID: NCT04815720
Status: COMPLETED
Last Update Posted: 2025-01-08
First Post: 2021-03-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Pepinemab in Combination With Pembrolizumab in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
Sponsor: Vaccinex Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module